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Focal intimal thickening is a feature of primary athero- 
sclerotic coronary lesions and restenotic lesions following 
percutaneous transluminal coronary angioplasty and other 
forms of vascular intervention, where it is the nonspecific 
response of the vessel wall to injury. The principal cellular 
component of the coronary plaque is the smooth muscle 
cell.’ Whether the smooth muscle cell in human coronary 
lesions is derived from cells circulating in the blood or from 
the vessel wall itself remains a matter for debate. On the 
basis of animal studies, it is generally presumed that the 
tunica media or subintimal space is the source of intimal 
smooth muscle cells.2-5 However, there is sound experi- 
mental evidence that smooth muscle cells recognized in a 
vascular plaque may originate in mural thrombus and not 
in the adjacent vessel wall. 6-8 Regardless of their source, 
these cells would normally be indistinguishable. Athero- 
sclerotic lesions developing in the coronary arteries after 
orthotopic heart transplantation provide a unique oppor- 
tunity to pursue the origin of cells within the coronary ath- 
erosclerotic plaque, as the donor and recipient invariably 
differ in genotype. Genetic differences may be demon- 
strated by the electrophoretic analysis of alleles from the 
highly polymorphic variable number of tandem repeats 
(VNTR) gene loci that occur widely in the human ge- 
nome.g,10 The Dl7S5/Dl7S30 VNTR locus, the DlS80/ 
DlS58 VNTR locus, and the Apo B 3’ VNTR locus (the 
hypervariable 3’ region of the apolipoprotein B gene) rep- 
resent independent, highly polymorphic deoxyribonucleic 
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acid (DNA) markers that may be used for the purpose 01 
biologic identification.“-” 
In this brief report, electrophoretic analysis of alleles 
from three separate VNTR loci, amplified by the polv- 
merase chain reaction (PCR) technique,16 was employed to 
compare the genotype of smooth muscle cells present in a 
human coronary lesion developing after heart transplanta- 
tion with that of the immediate postoperative myocardial 
biopsy and that of recipient leukocytes. 
Methods. A 37-year-old man with end-stage heart failure 
caused by idiopathic dilated cardiomyopathy underwent 
orthotopic cardiac transplantation. The donor was a 34- 
year-old woman free of cardiac history. At the conclusion 
of the transplantation, a baseline myocardial biopsy (biop- 
sy 1) was taken from the right ventricle, placed in isopen- 
tane, and frozen immediately under liquid nitrogen (-70’ 
C). Yearly coronary angiograms were performed. After 5 
years, a new eccentric stenosis was evident in the circum- 
flex coronary artery (Fig. 1). Exercise thallium 201 perfu- 
sion scintigraphy was performed and confirmed a revers- 
ible defect in the left ventricular posterior wall. On this 
basis, the patient underwent, directional coronary atherec- 
tomy after giving informed consent. The tissue removed 
from the coronary artery (biopsy 2) was frozen in an iden- 
tical manner t,o biopsy 1. Venous blood was drawn from the 
patient for DNA profiling studies. The presence of smooth 
muscle cells in the coronary artery lesion was assessed with 
immunostaining. A portion of the coronary tissue retrieved 
during directional coronary atherectomy was formalin- 
fixed and embedded in paraffin. Sections 5 pm thick were 
prepared and stained by means of a monoclonal antibody 
specific for smooth muscle cell tu-actin.” Genomic DNA 
was extracted from biopsies 1 and 2 by lysing the tissue in 
400 ~1 of a solution containing 10 mmol/L tris-HCl (pH 
8.0)/10 mmol/L NazEDTA/lOO mmol/L NaCl/O.S”;. so- 
dium dodecylsulfate (SDS)/500 ~1 proteinase-K in a shak- 
ing water bath at 65” C for 4 hours. The lysis mixture was 
extracted once with tris-saturated phenol, once with chlo- 
roform:isoamylalcohol (24:1), and subsequently precipi- 
tated in ethanol. The DNA was dissolved in a solution con- 
taining 10 mmol/L tris-HCI (pH 8.0)/l mmol/L NazEDTA; 
DNA from biopsy 1 was dissolved in 15 ~1 (final concentra- 
tion 880 ng fill’) and DNA from biopsy 2 was dissolved 
in 20 ~1 (final concentration 20 ng . ~1~*). To extract 
genomic DNA from whole blood, the erythrocytes were first 
lysed by adding 3 volumes of lysis buffer containing 155 
mmol/L NH4Cl/lO mmol/L KHCOs/l mmol/L NazEDTA 
and incubating on ice for 30 minutes. After centrifugation, 
a protocol identical to that detailed for biopsies 1 and 2 was 
followed for the leukocyte pellet. The final DNA concen- 
tration was 800 ng . &I. The yield of genomic DNA from 
whole blood was 35 pg . ml ‘. For the polymerase chain 
reaction, genomic DNA (10 ng) was added to a solution 
containing either 1.0 mmol/L MgCls (Dl7S5/S30 locus) or 
1.5 mmol/L MgC12 (DlSSO/S58 and Apo B 3’ loci) and 50 
mmol/L KCl/lO mmol/L tris-HCl (pH 8.3)/200 Fmol/L 
dNTPs/lO@c glycerol/O.2 mg ml-l acetylated BSA/300 
ng primers/l unit Taq polymerase, with 5% detergent SO- 
lution. Before temperature cycling, the solutions were 
Volume 125, Number 4 
American Heart Journal Strauss et al. 1177 
Fig. 1. A, Routine coronary angiogram 5 years post-transplant revealing an eccentric stenosis (arrow) in 
the circumflex coronary artery. (Original magnification x4.) 6, Control angiogram 1 year previously. No le- 
sion was evident. (Original magnification ~1.3.) 
overlaid with 50 ~1 mineral oil (Nujol, Plough, Inc., Mem- 
phis, Tenn.). After an initial denaturation of 4 minutes at 
94’ C, 30 cycles of varying incubation time and tempera- 
ture specific for each locus were performed in a thermal 
cycler apparatus (Biomed, Germany). Cycle details were 
the following: D17S5/S30 locus-denaturation 4 minutes 
at 94’ C, annealing 0.5 minutes at 55” C, primer extension 
4 minutes at 72’ C, final extension 10 minutes at 72” C; 
DlS80/S58 locus-denaturation 2 minutes at 94” C, an- 
nealing 2 minutes at 65’ C, primer extension at 4 minutes 
at 72’ C, final primer extension 10 minutes at 72’ C; Apo 
B 3’ locus-denaturation 4 minutes at 94’ C, annealing 6 
minutes at 58O C, primer extension 6 minutes at 58” C, fi- 
nal extension 10 minutes at 5%’ C. On completion of the 
polymerase chain reaction (PCR), 5 to 30 ~1 aliquots of the 
solutions were run on 9% polyacrylamide gel (acryla- 
mide:bisacrylamide, 37:l) in 1 X TAE (40 mmol/L tris-HCI 
(pH 7.4)/20 mmol/L sodium acetate/l mmol/L NasEDTA) 
for 1.5 hours at 200 V in a vertical slab gel electrophoresis 
apparatus placed in a buffer tank at 50” C.ls Following 
electrophoresis, the separation pattern was stained with 30 
pg . ml-l homidium bromide solution and subsequently 
documented by Polaroid photography (Polaroid Corp. 
Medical Products, Cambridge, Mass.) under 302 nm (UVP, 
Inc., San Gabriel, Calif.). Materials used were monoclonal 
antibody to smooth muscle cell a-actin (Dako, Copen- 
hagen, Denmark); proteinase-K, glycerol (E. Merck, Darm- 
stadt, Germany); dNTPs (Pharmacia, Uppsala, Sweden); 
acetylated BSA, detergent, ladder markers (Gibco, Grand 
Island, N.Y.); and Nujol mineral oil. The polymerase chain 
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Fig. 2. Coronary atherectomy specimen stained with monoclonal antibodies to smooth muscle cell cy-ac- 
tin. Intimal smooth muscle cells can be identified by their dark pigmentation. (Original magnification x50.) 
D17s.S 530 Apo B3’ 
Fig. 3. Gel electrophoresis of products of PCR amplification of the D17S5/S30, DlS80/S58, and Ap 
VNTR loci from genomic DNA. BI (biopsy 1) is donor myocardial tissue, B2 (biopsy ‘2) is coronary 
retrieved at directional atherectomy, and Blo is recipient venous blood. Ml represents the 1 kb 1 
marker, M2 the 123 bp ladder marker. See text for details. 
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reaction primer sequences for the three VTNR loci are: 
D17S5/S30 primer l-5’-CGAAGAGTGAAGTGCA- 
CAGG-3’ (20 mer) and primer 2--5’-CACAGTCTTTAT- 
TCTTCAGCG-3’ (21 mer); DlS80/S58 primer 1-5’- 
GAAACTGGCCTCCAAACACTGCCCGCCG-3’ (28 mer) 
and primer 2-5’-GTCTTGTTGGAGATGCACGTGC- 
CCTTGC-3’ (29 mer); and Apo B 3’ primer 3’-5’-CCT- 
TCTCACTTGGCAAATAC-3’ (20 mer). 
Results. The tissue obtained at directional coronary 
atherectomy (biopsy 2) contained cells bearing the mor- 
phologic appearance of smooth muscle cells but not ar- 
ranged with the typical architecture of the tunica media. 
These cells were identified by immunostaining as smooth 
muscle cells by their positive staining with anti-smooth 
muscle cell a-actin (Fig. 2). The result of gel electrophore- 
sis after PCR amplification of alleles of the D17S5/S30, 
DlS80/S58, and Apo B 3’ VNTR loci is shown in Fig. 3. Bi- 
opsy 1, biopsy 2, and recipient blood are denoted by Bl, B2, 
and Blo, respectively. Ml and M2 represent the 1 kb and 
123 bp ladder markers. For the D17S5/S30 locus (Fig. 3, left 
panel), PCR products of 372 base pairs (bp) and 550 bp 
were observed in recipient blood, the latter being only 
faintly visible because of inefficient amplification of larger 
alleles of this 10~~s.~’ For biopsy 1 and 2, there was a shared 
fragment of 236 bp, indicating homozygosity of the locus 
for this allele, and both showed fainter bands correspond- 
ing to the 372 bp fragment in recipient blood. This was 
more evident for biopsy 2. For the DlS80 locus (Fig. 3, 
center panel), two alleles of 420 bp and 460 bp were 
observed for recipient blood DNA while the biopsies were 
homozygous for an additional band of 510 bp. Again, 
fainter bands corresponding to recipient blood DNA frag- 
ments were apparent for the biopsies, more so for biopsy 2. 
For the Apo B 3’ locus (Fig. 3, right panel), three fragments 
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corresponding to 570,720, and 880 bp were seen for recip- 
ient blood. The 720 and 880 bp fragments also appeared in 
the biopsies, both of which had a further band of 690 bp. 
The intensity of the signals suggested that one of the alle- 
les, 720 bp, was shared with blood. The fainter bands cor- 
responding to the blood pattern that were evident for all 
three loci in the biopsies were further assessed by image 
analysis of the Polaroid photograph. This indicated that 
the intensity of the blood-specific bands relative to the bi- 
opsy-specific bands for the three loci was approximately 
10%. 
Comments. With the advent of directional atherectomy, 
it has become possible to perform biopsies on human cor- 
onary plaque tissue and, with advances in molecular 
biologic techniques, to address fundamental questions re- 
lated to the development of atherosclerotic lesions. The 
coronary artery lesion arising de novo in the transplanted 
heart is probably the sole human clinical setting in which 
the origin, that is, blood-borne versus vessel wall-derived, 
of smooth muscle cells found in an intimal lesion can be in- 
vestigated. In this report, the cells within a lesion that de- 
veloped in the circumflex coronary artery of a transplanted 
heart were principally of donor genotype, bearing similar 
genetic features to an immediate post-transplant myocar- 
dial biopsy. Thus these cells originated in the vessel wall. 
However, PCR fragments corresponding to recipient DNA 
were also identified in the coronary tissue, more apparent 
for the D17S5/S30 and DlS80/S58 loci. There are two pos- 
sible explanations. As comparable bands (albeit less in- 
tense) were seen in the myocardial biopsy specimen taken 
directly after transplantation, contamination with recipi- 
ent blood during removal of the specimens must have oc- 
curred. It remains feasible though, that cells derived from 
circulating recipient blood made up some part of the lesion. 
For this to be so, in view of the experimental evidence,6-8 
previous spontaneous plaque rupture with ensuing mural 
thrombus deposition would have to be postulated as the 
setting for the ingrowth of circulatory cells. This is not un- 
reasonable. Plaque rupture is thought to occur commonly 
in the general population with coronary artery disease,ig, 2o 
in whom it need not be associated with symptoms. Indeed, 
symptoms would not be expected in a heart transplant re- 
cipient. In conclusion, the electrophoresis of VNTR loci 
amplified by the PCR technique indicated that the cells 
predominant in a de novo coronary artery lesion following 
heart transplantation originated in the vessel wall. Cells of 
circulatory origin, which contributed as much as 10 7; of the 
genetic material associated with the lesion, may have been 
present as a result of contamination, but we are not enti- 
tled to exclude the role of these circulating cells in the de- 
velopment of the lesion. 
In summary, the principal cellular component of vascu- 
lar intimal lesions in primary atherosclerosis and resteno- 
sis is the smooth muscle cell. It is believed that these cells 
originate in the vascular media or subintima, but they may 
also generate from circulating cells within mural thrombus. 
We compared the genetic characteristics of cells from a 
novel coronary artery lesion in a transplanted heart with 
those of the heart itself (donor genotype) and those of re- 
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cipient blood leukocytes (recipient genotype). Transplant 
heart coronary intimal tissue was retrieved at directional 
atherectomy. Intimal smooth muscle cells were identified 
by staining with anti-smooth muscle cell a-actin. Electro- 
phorectic analysis of polymorphic VNTR loci, amplified by 
the PCR technique, was used to compare this tissue with 
a post-transplant baseline myocardial biopsy and with re- 
cipient blood. DNA extracted from intimal cells was 
predominantly similar to that of the donor myocardium, 
but features of recipient DNA were also noted in both in- 
tima and, to a lesser extent, in myocardium. Smooth mus- 
cle cells in a novel coronary artery lesion in a transplanted 
heart were principally derived from the vessel wall. The 
presence of cells of circulatory origin may be ascribed to 
contamination with recipient blood at biopsy, but a contri- 
bution of circulating cells to the formation of the lesion is 
not excluded. 
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Morbidity of endomyocardial biopsy in 
cardiac transplant recipients 
Geetha Bhat, PhD, MD, Susan Burwig, BSN, MA, and 
Richard Walsh, MD Cincinnati, Ohio 
The success rate of cardiac transplantation has greatly im- 
proved with the use of the endomyocardial biopsy for 
monitoring allograft rejection.‘, 2 Although many noninva- 
sive techniques have been used in an attempt to diagnose 
rejection, endomyocardial biopsy continues to be the gold 
standard and accepted diagnostic tool in assessment of re- 
jection in the transplanted heart. Two studies have com- 
pared the procedural complications of endomyocardial bi- 
opsies between heart transplant recipients and nonrecipi- 
ents with cardiomyopathy. Although endomyocardial 
biopsy in transplant recipients is generally safe, the inci- 
dence of serious complications is 0.3 % to 0.7 Cb :-5 and there 
is a definite morbidity and mortality associated with the 
procedure. This study reviews the procedural complica- 
tions of 96 orthotopic heart transplant recipients who un-. 
derwent 1565 endomyocardial biopsy procedures for rou- 
tine surveillance for cardiac allograft rejection in a single 
institution. 
Records of a consecutive series of heart transplant 
recipients who underwent endomyocardial biopsy proce- 
dures between July 1990 and May 1992 were retrospec- 
tively reviewed. All major and minor procedural complica- 
tions during and after the procedures (an average of 2 hours 
of observation in the cardiac catheterization laboratory 
and/or the cardiac transplant clinic) were recorded. The 
right internal jugular vein was used in 1525 (97.4’;) proce- 
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dures, and the subclavian approach was used in 40 (2.6 ( I 
procedures when internal jugular venous access was not 
obtainable. The Stanford method” for right ventricular 
endomyocardial biopsy procedure was used. Right heart 
pressures were measured before and after the biopsy spec 
imens were obtained. All procedures were performed by, OI 
under the direct supervision of one of three attending car- 
diologists who were experienced in the performance of en- 
domyocardial biopsies. Myocardial tissue samples that 
were adequate for diagnosis were obtained during all pro- 
cedures. One thousand five hundred and sixty-two (99.8’ I I 
biopsy procedures were performed without complications. 
There were no major complications (defined as events that, 
resulted in prolongation of hospital stay or death). Three 
patients experienced the following minor complications 
(defined as those that could be managed without prolong- 
ing the observation time in the cardiac catheterization lab- 
oratory and/or clinic). One patient had a 15’, pneumo- 
thorax, which spontaneously resolved at the time of l-week 
follow-up chest roentgenogram. Two patients complained 
of right shoulder and arm discomfort after the biopsy pro- 
cedure. One of these patient,s underwent a neurologic eval- 
uation and was diagnosed with brachial plexus irritation. 
which resolved with physical therapy. The second patient’s 
discomfort resolved spontaneously in 2 weeks. None of the 
patients had infection related to biopsy, and no significant 
arrhythmias such as atria1 flutter, atria1 fibrillation, or 
ventricular tachycardia were observed during t.he proce- 
dure. 
Endomyocardial biopsy remains the standard for diag- 
nosis of acute allograft rejection in cardiac transplant re- 
cipients. Although it is frequently performed and fairly 
simple, the literature reports a definite morbidity and 
mortality associated with the procedure. Complications 
include cardiac perforation, pneumothorax, arrhythmias, 
neck hematoma, and transient right laryngeal nerve irrita- 
tions. This study documents that the overall complication 
rate in cardiac transplant recipients who undergo endo- 
myocardial biopsy is 0.2”, This is a lower incidence than 
thatreportedpreviouslyintheliterature.Insummary,endo- 
myocardial biopsy procedure complications are extremely 
low for experienced operators and can be performed with 
no mortality and minimal morbidity in cardiac transplant 
recipients. 
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